Sort
21,453 grants matching “tuberculosis”
CD8 T Cells and Immunity to Tuberculosis in Old Mice
$309,061Joanne Turner · Ohio State University · R01 · FY2007 · AG
Adjunct Vitamin A Therapy for Tuberculosis and HIV/AIDS
$309,055Johns Hopkins University · R01 · FY2003 · AI
Characterization of Mycobacterial Sigma Factors
$309,040Children'S Hospital Boston · R01 · FY2001 · AI
M Tuberculosis and Host-Defense Mechanisms
$308,938University Of North Carolina Chapel Hill · R01 · FY2005 · AI
Discovering novel natural products from fungal species
$308,925Bahar Behsaz · Chemia Biosciences, Inc. · R43 · FY2024 · GM
Hepatotoxicity Clinical Research Network
$308,904University Of California San Francisco · U01 · FY2003 · DK
Hepatotoxicity Clinical Research Network
$308,904University Of California San Francisco · U01 · FY2004 · DK
Innovative approachees for tuberculosis control in Braz*
$308,750Jose Roberto Lapa E Silva · Federal University Of Rio De Janeiro · U2R · FY2006 · TW
Tandemly Repetitive Proteins in Mycoplasmas
$308,723Kevin F Dybvig · University Of Alabama At Birmingham · R01 · FY2010 · AI
Alcohol and Reactivation TB
$308,706Louisiana State Univ Hsc New Orleans · R01 · FY2004 · AA
ANTIGEN SPECIFIC ACTIVATION AND HIV REPLICATION
$308,611University Of Pennsylvania · R01 · FY2000 · HL
Discovering New Anti-Tuberculosis Drugs
$308,603Michael G Thomas · University Of Wisconsin-Madison · R01 · FY2007 · AI
Purchase of Analytical Ultracentrifuge for Molecular Biophysics at Florida State
$308,578Timothy M Logan · Florida State University · S10 · FY2007 · RR
Emerging Infectious Disease Scholars at Brown University
$308,566Timothy P Flanigan · Brown University · R25 · FY2019 · AI
Animal Models Core
$308,466Randall J Basaraba · Brigham And Women'S Hospital · U19 · FY2019 · AI
Case Clinical Trials Unit
$308,403George Yendewa · Case Western Reserve University · UM1 · FY2025 · AI
A novel whole ORFeome approach to identify CD8+ T cell responses to S. Typhi prot
$308,378Marcelo B. Sztein · University Of Maryland Baltimore · U19 · FY2010 · AI
CD1c presentation of self glycolipids to T cells
$308,373Brigham And Women'S Hospital · R01 · FY2005 · AR
ANTIGEN SPECIFIC ACTIVATION AND HIV REPLICATION
$308,329University Of Pennsylvania · R01 · FY2001 · HL
Immune-mediated adverse drug reactions to HIV and TB treatments in South Africa: predict, prevent and improve long-term outcomes (IMARI SA study)
$308,214Graeme Ayton Meintjes · University Of Cape Town · R01 · FY2025 · AI
Evaluating the Role of L,D-Transpeptidases in Mycobacterial Pathogenesis
$308,190Kimberly Elizabeth Beatty · Oregon Health & Science University · R01 · FY2025 · AI
The Mycobacterium Tuberculosis Dormancy Program
$308,133University Of Colorado Denver · R01 · FY2005 · AI
Molecular determinants of lung cancer in HIV infected and uninfected individuals in Uganda and Tanzania
$308,055Stanton L Gerson · Case Western Reserve University · U54 · FY2020 · CA
HIV-associated Tuberculosis Training Program (HATTP)
$308,041Graeme Ayton Meintjes · University Of Cape Town · D43 · FY2021 · TW
ANTIGEN SPECIFIC ACTIVATION AND HIV REPLICATION
$308,039University Of Pennsylvania · R01 · FY2002 · HL